Fate Therapeutics Reports Third Quarter 2015 Financial Results

Go back to Fate Therapeutics Reports Third Quarter 2015 Financial Results
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.62 --0 (-0%)
Previous Close $2.62    52 Week High $4.76 
Open $2.62    52 Week Low $1.46 
Day High $2.62    P/E N/A 
Day Low $2.62    EPS $-1.91 
Volume 208,962